Effectiveness of CelluTome Epidermal Harvesting System in Autologous Skin Grafting of Chronic Wound Patients

Withdrawn before enrolling · Not applicable

Conditions studied: Wounds and Injuries

In brief

This is multi-center prospective, longitudinal case series with comparison to historical controls.

Key facts

Study ID

NCT02492048

Run by

LifeBridge Health

People needed

0

Starts

2014-12-16

Expected to finish

2018-12-01

Last updated by the study team

2018-03-15

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Signed Informed Consent
• Patients requiring split-thickness skin grafting with non-infected wounds
• Age of participants: 18 years and above at the time of informed consent
• Gender: Male or Female
• Subjects who will be locally available for the next 6 months.

You may not qualify if…

• Infected chronic wound
• Patients who are unable to adhere to scheduled study visits
• Patients who have severe arterial insufficiency requiring vascular intervention to restore adequate blood flow
• Patients who have an active drug/alcohol dependence or abuse history
• Use of Investigational Agents/Devices on study or within 30 days prior to informed consent or within 30 days prior to use of device.

Where it is running

• Rubin Institute for Advanced Orthopedics, Sinai Hospital of Baltimore, LifeBridge Health — Baltimore, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.